Akos Czibere
Chief Medical Officer at Aktis Oncology, Inc. (AKTS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 24SEC | AKTSAktis Oncology, Inc. | Sell Plan | 5,0997,401 held (−41%) | $20.19 | $103K | -10.1% |
| Sep 24SEC | AKTSAktis Oncology, Inc. | Sell Plan | 7,401 | $21.03 | $156K | -13.7% |
| Jul 10SEC | AKTSAktis Oncology, Inc. | Sell | 14,80035,200 held (−30%) | $27.13 | $402K | -33.1% |
| Jul 10SEC | AKTSAktis Oncology, Inc. | Sell | 30,8294,371 held (−88%) | $27.95 | $862K | -35.1% |
| Jul 10SEC | AKTSAktis Oncology, Inc. | Sell | 4,371 | $28.71 | $125K | -36.8% |
- Sell
Chief Medical Officer Akos Czibere sold $103K of AKTS at $20.19 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Akos Czibere sold $156K of AKTS at $21.03 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Akos Czibere sold $402K of AKTS at $27.13 — cuts the stake by 30%.
- Sell
Chief Medical Officer Akos Czibere sold $862K of AKTS at $27.95 — cuts the stake by 88%.